Opinion-Editorial NEWS

Here are some reminders

Safe and effective medications for coronavirus disease (COVID-19) are available in the country and these are “essential” in exiting the pandemic, adult infectious disease specialist Dr. Edsel Maurice Salvaña said on Friday, Feb. 11.

“No exception.”

From straight out of left field, Presidential Spokesperson Harry Roque denied on Tuesday night, Sept. 7 any relation to a man in a TikTok video who called him his “biological dad”.

The Department of Health (DOH) said it is currently facing challenges in sourcing anti-inflammatory drug tocilizumab which is being used in treating coronavirus disease (COVID-19) patients.

The National Kidney and Transplant Institute (NKTI) announced that it will suspend the dispensing of coronavirus disease (COVID-19) drugs remdesivir and tocilizumab after reaching “critical stock level.”

The Philippine Hospital Association (PHA) said that it is not right to accuse various hospitals in the country of overpricing antiviral drug Remdesivir that is being used for the treatment of coronavirus disease (COVID-19) patients.

A pediatric neurosurgeon asked for help on social media after he found out that a coronavirus disease (COVID-19) drug was being sold using receipts under his name.

The Department of Health (DOH) warned the public against overpricing Remdesivir, an investigational drug used in treating coronavirus disease (COVID-19) patients.

The World Health Organization (WHO) is further conducting studies on the use of antiviral drug Remdesivir against coronavirus disease (COVID-19), the Department of Science and Technology- Philippine Council for Health Research and Development (DOST-PCHRD) said on Thursday, May 20.

The Department of Health (DOH) said it is not procuring the antiviral drug Remdesivir being used by coronavirus disease (COVID-19) patients.

The government has firmed up contingency plans to secure more medical oxygen supplies as well as Remdevisir to help with the treatment of coronavirus patients in the country.

The Food and Drug Administration (FDA) on Monday, May 3, clarified that Remdesivir, an investigational drug currently being used in the country on patients with coronavirus disease (COVID-19), has no Certificate of Product Registration (CPR) in the Philippines.

The Philippines is now looking at other suppliers of investigational drugs against the coronavirus disease (COVID-19) as India, a major drug supplier worldwide, is now battling a surge in infections.

Science-savvy consumer advocacy group Alyansa ng mga Grupong Haligi ng Agham at Teknolohiya Para sa Mamamayan (AGHAM) underscored on Sunday, April 25 a key difference between Ivermectin and Remdesivir, two popular drugs being repurposed for the treatment of the dreaded coronavirus disease (COVID-19).

The Department of Health (DOH) on Friday, April 23 warned the public on the overpricing of Remdesivir.